摘要:
Compounds of the formula in which R¹ is alkyl; R² and R³ are alkyl or taken together they are polymethylene, R² and R³ complete a 5-norbornen-2-yl moiety; X is -CO₂-, -OCO-, -OCO₂-, -N(R⁷)CO-, -NHNHCO-, -ON(R⁷)CO-, -CON(R⁷)-, -N(R⁷)CO₂-, -OCON(R⁷)- or -N(R⁷)CON(R⁸)-, wherein R⁷ and R⁸ are, independently, hydrogen, alkyl, phenyl, benzyl, substituted phenyl or substituted benzyl in which the substituents are halo, alkyl, alkoxy, cyano, nitro or perhalomethyl; R⁴ is hydrogen or alkyl; R⁵ is hydrogen, alkyl, hydroxyalkyl, phenyl, benzyl, substituted phenyl or substituted benzyl in which the substituents are hydroxy, halo, alkyl, alkoxy, trifluoromethyl, nitro, cyano, carbalkoxy, carboxamido, amino, alkylamino, or dialkylamino; R⁶ is phenyl, benzyl, 2-, 3-, or 4-pyridinyl, 2-pyrimidinyl or 2-pyrazinyl, any of which may be substituted by one or more hydroxy, halo, alkyl, alkoxy, trifluoromethyl, nitro, cyano, carbalkoxy, carboxamido, amino, alkylamino or dialkylamino; n is one of the integers 1, 2, 3, 4 or 5; or a pharmaceutically acceptable salt thereof, with the proviso that when X is -CON(R⁷)- and R⁷ is alkyl, R⁶ is other than 2-pyrimidinyl, are antidepressant and/or anxiolytic agents.
摘要:
Compounds of the formula: in which R 1 is alkyl; R 2 and R 3 are alkyl or taken together they are polymethylene, R 2 and R 3 complete a 5-norbornen-2-yl moiety; X is -CO 2 -, -OCO-, -OCO 2 -, -N(R 7 )CO-, -NHNHCO-, -ON(R 7 )CO-, -CON(R 7 )-, -N(R 7 )CO 2 -, -OCON(R 7 )- or -N(R 7 )CON(R 8 )-, wherein R 7 and R 8 are, independently, hydrogen, alkyl, phenyl, benzyl, substituted phenyl or substituted benzyl in which the substituents are halo, alkyl, alkoxy, cyano, nitro or perhalomethyl; R 4 is hydrogen or alkyl; R 5 is hydrogen, alkyl, hydroxyalkyl, phenyl, benzyl, substituted phenyl or substituted benzyl in which the substituents are hydroxy, halo, alkyl, alkoxy, trifluoromethyl, nitro, cyano, carbalkoxy, carboxamido, amino, alkylamino or dialkylamino; R 6 is phenyl, benzyl, 2-, 3-, or 4-pyridinyl, 2-pyrimidinyl or 2-pyrazinyl, any of which may be substituted by one or more hydroxy, halo, alkyl, alkoxy, trifluoromethyl, nitro, cyano, carbalkoxy, carboxamido, amino, alkylamino or dialkylamino; n is one of the integers 1, 2, 3, 4 or 5; or a pharmaceutically acceptable salt thereof, with the proviso that when X is -CON(R 7 )- and R 7 is alkyl, R 6 is other than 2-pyrimidinyl, are antidepressant and/or anxiolytic agents.
摘要:
Novel phenethylamine derivatives are central nervous system antidepressants. The compounds are those having the formula where A is where the dotted line represents optional unsaturation;
R 1 and R 7 are, independently, hydrogen or C 1 -C 6 alkyl; R 2 is C 1 -C 6 alkyl; R 4 is hydrogen, C 1 -C 4 alkyl, formyl or C 2 -C 7 alkanoly; R 5 and R 6 are hydrogen or defined substituents and n is 0,1,2,3, or 4 and their pharmaceutically acceptable salts. Novel intermediates for the preparation of these compounds include those of the formulae
摘要:
This invention provides anxiolytic/antidepressant agents of the formula:
in which R 1 is alkyl of 1 to 6 carbon atoms, cycloalkyl of 5 to 7 carbon atoms, aryl of 6 to 10 carbon atoms or arylalkyl of 7 to 12 carbon atoms; R 2 is hydrogen or alkyl of 1 to 6 carbon atoms; R 3 is phenyl, benzyl, substituted phenyl, or substituted benzyl in which the substituents are hydroxy, halo, alkoxy of 1 to 6 carbon atoms, trifluoromethyl, nitro, cyano, alkoxycarbonyl of 2 to 7 carbon atoms, amino or dialkylamino in which each alkyl group contains 1 to 6 carbon atoms; or a pharmaceutically acceptable salt thereof.
摘要:
Compounds of the formula in which R¹ is alkyl; R² and R³ are alkyl or taken together they are polymethylene, R² and R³ complete a 5-norbornen-2-yl moiety; X is -CO₂-, -OCO-, -OCO₂-, -N(R⁷)CO-, -NHNHCO-, -ON(R⁷)CO-, -CON(R⁷)-, -N(R⁷)CO₂-, -OCON(R⁷)- or -N(R⁷)CON(R⁸)-, wherein R⁷ and R⁸ are, independently, hydrogen, alkyl, phenyl, benzyl, substituted phenyl or substituted benzyl in which the substituents are halo, alkyl, alkoxy, cyano, nitro or perhalomethyl; R⁴ is hydrogen or alkyl; R⁵ is hydrogen, alkyl, hydroxyalkyl, phenyl, benzyl, substituted phenyl or substituted benzyl in which the substituents are hydroxy, halo, alkyl, alkoxy, trifluoromethyl, nitro, cyano, carbalkoxy, carboxamido, amino, alkylamino, or dialkylamino; R⁶ is phenyl, benzyl, 2-, 3-, or 4-pyridinyl, 2-pyrimidinyl or 2-pyrazinyl, any of which may be substituted by one or more hydroxy, halo, alkyl, alkoxy, trifluoromethyl, nitro, cyano, carbalkoxy, carboxamido, amino, alkylamino or dialkylamino; n is one of the integers 1, 2, 3, 4 or 5; or a pharmaceutically acceptable salt thereof, with the proviso that when X is -CON(R⁷)- and R⁷ is alkyl, R⁶ is other than 2-pyrimidinyl, are antidepressant and/or anxiolytic agents.
摘要:
Compounds of the formula: in which R 1 is alkyl; R 2 and R 3 are alkyl or taken together they are polymethylene, R 2 and R 3 complete a 5-norbornen-2-yl moiety; X is -CO 2 -, -OCO-, -OCO 2 -, -N(R 7 )CO-, -NHNHCO-, -ON(R 7 )CO-, -CON(R 7 )-, -N(R 7 )CO 2 -, -OCON(R 7 )- or -N(R 7 )CON(R 8 )-, wherein R 7 and R 8 are, independently, hydrogen, alkyl, phenyl, benzyl, substituted phenyl or substituted benzyl in which the substituents are halo, alkyl, alkoxy, cyano, nitro or perhalomethyl; R 4 is hydrogen or alkyl; R 5 is hydrogen, alkyl, hydroxyalkyl, phenyl, benzyl, substituted phenyl or substituted benzyl in which the substituents are hydroxy, halo, alkyl, alkoxy, trifluoromethyl, nitro, cyano, carbalkoxy, carboxamido, amino, alkylamino or dialkylamino; R 6 is phenyl, benzyl, 2-, 3-, or 4-pyridinyl, 2-pyrimidinyl or 2-pyrazinyl, any of which may be substituted by one or more hydroxy, halo, alkyl, alkoxy, trifluoromethyl, nitro, cyano, carbalkoxy, carboxamido, amino, alkylamino or dialkylamino; n is one of the integers 1, 2, 3, 4 or 5; or a pharmaceutically acceptable salt thereof, with the proviso that when X is -CON(R 7 )- and R 7 is alkyl, R 6 is other than 2-pyrimidinyl, are antidepressant and/or anxiolytic agents.
摘要:
The invention discloses compounds of the formula (I) wherein R¹ is 1-adamantyl, 3-methyl-1-adamantyl, 3-noradamantyl, unsubstituted or substituted-2-indolyl, 3-indolyl, 2-benzofuranyl and 3-benzofuranyl wherein the substituents are selected from lower alkyl, lower alkoxy and halo; R² is unsubstituted or substituted phenyl, benzyl, pyridinyl, pyrimidinyl or pyrazinyl, wherein the substituents are selected from lower alkyl, lower alkoxy, trifluoromethyl and halo; R³ is H or lower alkyl of 1 to 3 carbon atoms, n is the integer 0 or 1; m is an integer from 2 to 5, and the pharmaceutically acceptable salts thereof which possess central nervous system activity.
摘要:
The invention discloses compounds of the formula (I) wherein R¹ is 1-adamantyl, 3-methyl-1-adamantyl, 3-noradamantyl, unsubstituted or substituted-2-indolyl, 3-indolyl, 2-benzofuranyl and 3-benzofuranyl wherein the substituents are selected from lower alkyl, lower alkoxy and halo; R² is unsubstituted or substituted phenyl, benzyl, pyridinyl, pyrimidinyl or pyrazinyl, wherein the substituents are selected from lower alkyl, lower alkoxy, trifluoromethyl and halo; R³ is H or lower alkyl of 1 to 3 carbon atoms, n is the integer 0 or 1; m is an integer from 2 to 5, and the pharmaceutically acceptable salts thereof which possess central nervous system activity.
摘要翻译:本发明公开了式(I)的化合物,其中R 1是1-金刚烷基,3-甲基-1-金刚烷基,3-降金刚烷基,未取代的或取代的-2-吲哚基,3-吲哚基,2-苯并呋喃基 和3-苯并呋喃基,其中取代基选自低级烷基,低级烷氧基和卤素; R 2是未取代或取代的苯基,苄基,吡啶基,嘧啶基或吡嗪基,其中取代基选自低级烷基,低级烷氧基,三氟甲基和卤素; R 3是H或1至3个碳原子的低级烷基,n是整数0或1; m是2至5的整数,及其药学上可接受的盐,其具有中枢神经系统活性。